Hepatitis C Treatment Options in 2023
From direct-acting antiviral medications and interferon-based therapies, find out the current treatment options for hepatitis C in 2023.
Continue reading »
From direct-acting antiviral medications and interferon-based therapies, find out the current treatment options for hepatitis C in 2023.
Continue reading »
Find out some causes of hepatitis C treatment failure as well as steps you can take if your hep C treatment isn't working.
Continue reading »
Here are some options to consider, including oral antiviral medications, for treating hepatitis C in 2022.
Continue reading »
Recent research suggests that shortening your course of hepatitis C treatment may increase your risk of relapse.
Continue reading »
Learn about the recommendations for the treatment of HCV in 2021. While we are still looking for a hepatitis C vaccine and pushing for earlier screening and identification of those infected, there are 4 diet and lifestyle changes you can make now to help heal your liver.
Continue reading »
Discover what it means to treat hepatitis C with the 'Netflix' model, which states are participating, and if the payment model is beneficial.
Continue reading »
A uniquely effective and affordable cure against Hepatitis C (HCV) has been unearthed by the non-profit Drugs for Neglected Disease Initiative (DNDI) and a for profit Egyptian company called Pharco Pharmaceuticals. The wonderful formulation is a combination of the drugs sofosbuvir and ravidasvir and is currently undergoing a multicenter phase III trial (STORM-C).
Continue reading »
As we enter a new decade, take a look back at the progress made in 2019 with Hepatitis C drugs, as well as the awareness and elimination goals planned for the virus in 2020 and beyond.
Continue reading »
Leading research indicates vastly improved outcomes for HCV and liver cancer patients using all-oral direct-acting antiviral treatments.
Continue reading »
The New Year is upon us and already there’s no shortage of Hepatitis C treatment news. Several big announcements in mid-2018 set the stage for generic versions of many Hepatitis C drugs to hit the market by early 2019.
Continue reading »
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window